BCL2 and hepatocellular carcinoma: For example, miR-9-5p promotes HCC progression via inhibition of KLF4, thereby activating AKT/mTOR signaling, resulting in increased expression of the anti-apoptotic protein Bcl-2, and reduced expression of the pro-apoptotic protein Bax [60].